The Versi PD Cycler System conceived and developed by Debiotech and licensed to Fresenius Medical Care receives FDA clearance
Versi™PD will begin a limited rollout in 2022 with more widespread availability planned in 2023 and beyond.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Apr 22
Versi™PD will begin a limited rollout in 2022 with more widespread availability planned in 2023 and beyond.
06 Apr 22
ST Set previously obtained FDA Emergency Use Authorization (EUA) to help meet increased demand for continuous renal replacement…
16 Feb 22
The new Miyazaki plant will be designed to realise a smart factory by speeding up manufacturing automation and…
06 Jan 22
Optilume is a minimally invasive alternative to traditional endoscopic treatments for male anterior urethral strictures and offers immediate…
17 Dec 21
The FDA Breakthrough Device Designation helps patients with ESRD vein dilation indication to have enhanced access to FA-1…
30 Nov 21
The FDA approval enables manufacturing of the cartridges in North America, which localises production, reduces cost and mitigates…
20 Sep 21
JMS Co. Ltd will distribute the advanced portfolio of Fresenius Medical Care’s home dialysis systems in Japan, including…
22 Dec 20
University of Kansas School of Medicine urology professor Wilson Molina performed the first case as part of the…
10 Dec 20
The Israeli medical device firm has acquired the intellectual property and other assets related to the use of…
09 Dec 20
The system provides continuous renal replacement therapy (CRRT) to paediatric patients, weighing between 2.5 and 10kg